The pleiotropic effects of Kaposi's sarcoma herpesvirus.
about
Identification of bZIP interaction partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil arraysViruses associated with human cancerThe KSHV RNA regulator ORF57: target specificity and its role in the viral life cycleA Structural Basis for BRD2/4-Mediated Host Chromatin Interaction and Oligomer Assembly of Kaposi Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus LANA ProteinsUpregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stressKaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivationActivation of p90 ribosomal S6 kinase by ORF45 of Kaposi's sarcoma-associated herpesvirus and its role in viral lytic replicationViral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication.K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.Kaposi's Sarcoma-Associated Herpesvirus Hijacks RNA Polymerase II To Create a Viral Transcriptional Factory.Chromatin organization of gammaherpesvirus latent genomes.View and review on viral oncology research.Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation.Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway.Carcinogenic viruses and solid cancers without sufficient evidence of causal association.Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis.KSHV/HHV8-associated lymphomas.An immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infectionRecruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANAMolecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesisSphingosine kinase-2 maintains viral latency and survival for KSHV-infected endothelial cells.Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion.Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV.Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP.Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus.The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNAProtein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen.Human herpesvirus 8 genotype E in patients with Kaposi sarcoma, Peru.KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging ConceptsIdentification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANAA case report of immunosuppression-related Kaposi's sarcoma after autologous stem cell transplantation.The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targetsNotch and Wnt signaling: mimicry and manipulation by gamma herpesviruses.Professional antigen presenting cells in human herpesvirus 8 infection.CTCF regulates Kaposi's sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming.Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virusRegulation of telomerase and telomeres: human tumor viruses take control.Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.
P2860
Q24297419-649859A6-B58A-44E2-B864-ECC3A8E09930Q24653900-9251DD99-D220-4D43-BE90-F0A77613C14BQ26771969-A378365C-85AE-40CB-A17E-2AFC80BA631EQ27680409-7D032CEE-47D9-4A11-8041-E2C7A20BAEA3Q28472699-57FE9DF5-6A8A-4245-BFF7-1325AE3E05B9Q28535568-FCEE4379-389B-407B-B795-2A811D8AAAB7Q30441657-A643CF73-65D1-4F09-BC16-3F77FA7514DCQ33268403-DEF8FC1D-51A1-4CA6-892A-A32924740741Q33303677-A60AA38C-351D-46F0-92E0-9034F25EEBF4Q33560572-4057571D-70FE-41D8-8657-0C02F99981D3Q33690895-5355E920-BD67-400F-9E3F-41406621CE49Q33729584-96A737CE-4CC4-42B9-81D4-9A3613DEBF6EQ33894872-DB918ACB-76CB-4176-9506-49FEF30D6E63Q34005284-3399A32B-8FB5-493D-AECC-9A50677D3AE1Q34092628-4E260CD7-4043-4134-A8AE-1ACEA0405E70Q34320412-C06BDE1A-F271-4E37-80EE-8A4B514146ACQ34580878-3680AC2A-B658-4B71-BF99-72345DEE9BC4Q34711929-26368D0A-FF33-4B80-ABC0-8B10B467ADACQ35007502-A291FBE1-BC21-4F7A-88FB-2C397935FDF6Q35080754-D2F03A75-1B62-41A4-8796-01A3C59AD30CQ35124404-0979DA85-16D1-40D5-8880-533D4A76DA6FQ35204641-BB0F1453-F791-4456-8927-D0293E81648FQ35363036-71943D8B-94FB-4F72-8C08-15369B582A54Q35453657-0BFC8A30-5671-491B-BABF-1F4A5EAA2CCDQ35635192-0E48DE06-F6F1-415A-9AA6-957026B07D58Q35635202-CBFFCC0A-382D-4509-899E-E1B1898E30BDQ35669267-FB138554-8B3D-487F-A56D-0B0D0EC77DBFQ35774091-566B95AB-BBA9-4415-B776-F79DCA030BA8Q35806579-C04DAF76-A2F3-491D-A34D-A40F12B4E87CQ35810446-8E9EA58B-6BB4-4B8A-BD52-8A0955BE69B5Q35943531-B0814A34-8935-429A-88E6-7B984CB05A38Q35969629-2CAD9318-2D32-4E67-BD19-F888A3BB2F67Q36099076-FFC76DC1-C396-4577-8876-72242B6F2F24Q36316001-812F2613-7053-418D-A864-91E86EFE3941Q36480684-18211DDB-5EFD-4A7B-9585-25272B3119DAQ36546999-BE1142B0-D15E-423D-98D2-08FA0BFBDBC3Q36559926-43764A47-B6DF-463A-B64E-1FFB3CACA585Q36879345-04FB03BB-55CC-4D43-B027-54D3A13C1555Q37053343-8A52B540-237A-4E02-8C27-FA43EF03CBE0Q37088015-D781A474-A572-49C1-AD7A-7D448E5BA9FC
P2860
The pleiotropic effects of Kaposi's sarcoma herpesvirus.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The pleiotropic effects of Kaposi's sarcoma herpesvirus.
@ast
The pleiotropic effects of Kaposi's sarcoma herpesvirus.
@en
type
label
The pleiotropic effects of Kaposi's sarcoma herpesvirus.
@ast
The pleiotropic effects of Kaposi's sarcoma herpesvirus.
@en
prefLabel
The pleiotropic effects of Kaposi's sarcoma herpesvirus.
@ast
The pleiotropic effects of Kaposi's sarcoma herpesvirus.
@en
P2860
P356
P1476
The pleiotropic effects of Kaposi's sarcoma herpesvirus.
@en
P2093
Thomas F Schulz
P2860
P304
P356
10.1002/PATH.1904
P577
2006-01-01T00:00:00Z